Deal Watch: Shire, Allergan Move To Shore Up Core Franchises

 
• By Sukaina Virji, Beth Allan, Deanna Kamienski, Amanda Micklus, Maureen Riordan, Sten Stovall, and Jessica Merrill

Bristol acquires Cardioxyl and its Phase II congestive heart failure candidate as the latest deal to firm up its specialty drug pipeline, while Sanofi inks a cancer immunotherapy deal with BioNTech and a pair of diabetes-related partnerships with Hanmi and Lexicon.

More from Archive

More from Pink Sheet